Acro Biomedical (ACBM) 10-Q2023 Q1 Quarterly report

Filed: 2 Aug 23, 12:50pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Good

New words: accelerated, Calculation, chapter, charged, Commission, Data, directing, emergency, emerging, Employer, Expert, expire, expired, extended, Extension, feel, filer, global, Group, growth, Identification, Indiana, Instance, Interactive, IRS, issuer, July, jurisdiction, Label, Linkbase, lost, mark, minimal, organization, OTC, paragraph, permitted, practicable, preceding, publicly, registered, relaxed, renewed, resale, residual, Schema, service, shell, shorter, small, sophisticated, State, stream, submit, submitted, Suite, Taxonomy, terminate, thirteen, Tier, transition, view, viewing, Visionary

Removed: adverse, begun, beneficial, broad, comparison, condensed, consolidated, continuation, cover, curb, decreased, Delta, disposable, distribute, downturn, effort, Exhibit, facing, failure, fed, formulating, fourth, governmental, impact, impair, implementing, improve, improved, inability, infection, inspection, laid, line, marketable, modest, nutrition, Omicron, open, outbreak, People, perception, population, predict, priority, prolonged, quarantine, raw, Republic, response, resulted, retail, safe, satisfy, segment, Set, ship, smallest, spread, straight, successful, tested, ultimate, unpaid, vaccinated, variation

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ACBM similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Acro Biomedical Co., Ltd. (the “Company”) on Form 10-Q for period ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof, I, Pao-Chi Chu, chief executive officer and chief financial officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

	(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 2, 2023

By:

/s/ Pao-Chi Chu

Pao-Chi Chu

Chief Executive Officer and Chief Financial Officer

(Principal Executive Officer and Principal Financial Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.